Ken Griffin Third Harmonic Bio, Inc. Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 120,870 shares of THRD stock, worth $650,280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120,870
Previous 56,300
114.69%
Holding current value
$650,280
Previous $195,000
236.41%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding THRD
# of Institutions
108Shares Held
38.4MCall Options Held
62.7KPut Options Held
119K-
Atlas Venture Life Science Advisors, LLC10.4MShares$56 Million12.42% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.78MShares$31.1 Million1.12% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.82MShares$20.6 Million15.71% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.94MShares$15.8 Million0.7% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.92MShares$10.3 Million2.12% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $217M